Fluorine in PDB 7ala: Human Gch-Gfrp Inhibitory Complex
Enzymatic activity of Human Gch-Gfrp Inhibitory Complex
All present enzymatic activity of Human Gch-Gfrp Inhibitory Complex:
3.5.4.16;
Protein crystallography data
The structure of Human Gch-Gfrp Inhibitory Complex, PDB code: 7ala
was solved by
R.Ebenhoch,
H.Nar,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
39.74 /
1.85
|
Space group
|
C 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
162.745,
114.013,
113.83,
90,
130.34,
90
|
R / Rfree (%)
|
18.5 /
22
|
Other elements in 7ala:
The structure of Human Gch-Gfrp Inhibitory Complex also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Human Gch-Gfrp Inhibitory Complex
(pdb code 7ala). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 5 binding sites of Fluorine where determined in the
Human Gch-Gfrp Inhibitory Complex, PDB code: 7ala:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
Fluorine binding site 1 out
of 5 in 7ala
Go back to
Fluorine Binding Sites List in 7ala
Fluorine binding site 1 out
of 5 in the Human Gch-Gfrp Inhibitory Complex
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Human Gch-Gfrp Inhibitory Complex within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F302
b:59.3
occ:1.00
|
F19
|
A:5RW302
|
0.0
|
59.3
|
1.0
|
C6
|
A:5RW302
|
1.4
|
58.5
|
1.0
|
C3
|
A:5RW302
|
2.3
|
58.3
|
1.0
|
C4
|
A:5RW302
|
2.4
|
57.8
|
1.0
|
NE2
|
J:GLN9
|
2.8
|
27.5
|
1.0
|
CB
|
J:GLN9
|
3.4
|
22.7
|
1.0
|
O
|
A:HOH448
|
3.4
|
42.5
|
1.0
|
CG
|
J:GLN9
|
3.4
|
25.6
|
1.0
|
CD
|
J:GLN9
|
3.5
|
28.3
|
1.0
|
C1
|
A:5RW302
|
3.6
|
57.5
|
1.0
|
CB
|
J:GLN75
|
3.6
|
22.0
|
1.0
|
C2
|
A:5RW302
|
3.6
|
56.8
|
1.0
|
OD2
|
A:ASP237
|
3.9
|
29.9
|
1.0
|
C5
|
A:5RW302
|
4.1
|
55.7
|
1.0
|
CG
|
J:GLN75
|
4.2
|
26.3
|
1.0
|
O
|
E:HOH472
|
4.4
|
52.3
|
1.0
|
O
|
J:ILE10
|
4.4
|
22.9
|
1.0
|
CA
|
J:GLN9
|
4.5
|
22.2
|
1.0
|
O
|
J:GLN75
|
4.6
|
22.1
|
1.0
|
OE1
|
J:GLN9
|
4.7
|
28.7
|
1.0
|
NE2
|
J:GLN75
|
4.8
|
30.9
|
1.0
|
O
|
J:HOH211
|
4.8
|
31.4
|
1.0
|
CG
|
A:ASP237
|
4.9
|
25.9
|
1.0
|
N
|
J:ILE10
|
4.9
|
23.4
|
1.0
|
CA
|
J:GLN75
|
4.9
|
19.9
|
1.0
|
C
|
J:GLN75
|
5.0
|
21.3
|
1.0
|
|
Fluorine binding site 2 out
of 5 in 7ala
Go back to
Fluorine Binding Sites List in 7ala
Fluorine binding site 2 out
of 5 in the Human Gch-Gfrp Inhibitory Complex
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Human Gch-Gfrp Inhibitory Complex within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F302
b:56.7
occ:1.00
|
F19
|
B:5RW302
|
0.0
|
56.7
|
1.0
|
C6
|
B:5RW302
|
1.4
|
57.5
|
1.0
|
C4
|
B:5RW302
|
2.4
|
57.3
|
1.0
|
C3
|
B:5RW302
|
2.4
|
57.4
|
1.0
|
O
|
I:HOH238
|
2.9
|
29.8
|
1.0
|
O
|
I:ILE10
|
3.3
|
24.4
|
1.0
|
C2
|
B:5RW302
|
3.6
|
56.9
|
1.0
|
C1
|
B:5RW302
|
3.6
|
56.6
|
1.0
|
C
|
I:ILE10
|
4.1
|
22.6
|
1.0
|
C5
|
B:5RW302
|
4.1
|
56.1
|
1.0
|
N
|
I:ARG11
|
4.1
|
21.2
|
1.0
|
CB
|
I:GLN9
|
4.3
|
22.4
|
1.0
|
O
|
I:GLN9
|
4.4
|
20.4
|
1.0
|
O
|
I:HOH255
|
4.5
|
36.2
|
1.0
|
O
|
I:HOH222
|
4.7
|
20.4
|
1.0
|
NA
|
I:NA101
|
4.7
|
25.1
|
1.0
|
C
|
I:GLN9
|
4.8
|
21.0
|
1.0
|
CG1
|
I:VAL14
|
4.9
|
24.3
|
1.0
|
O
|
I:HOH234
|
4.9
|
24.0
|
1.0
|
CG1
|
B:VAL233
|
4.9
|
27.5
|
1.0
|
|
Fluorine binding site 3 out
of 5 in 7ala
Go back to
Fluorine Binding Sites List in 7ala
Fluorine binding site 3 out
of 5 in the Human Gch-Gfrp Inhibitory Complex
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Human Gch-Gfrp Inhibitory Complex within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:F302
b:58.1
occ:1.00
|
F19
|
C:5RW302
|
0.0
|
58.1
|
1.0
|
C6
|
C:5RW302
|
1.4
|
56.3
|
1.0
|
C4
|
C:5RW302
|
2.3
|
56.0
|
1.0
|
C3
|
C:5RW302
|
2.3
|
55.3
|
1.0
|
O
|
B:HOH445
|
2.9
|
68.1
|
1.0
|
OE2
|
B:GLU236
|
2.9
|
64.2
|
1.0
|
O
|
B:HOH443
|
3.5
|
46.4
|
1.0
|
C2
|
C:5RW302
|
3.6
|
55.3
|
1.0
|
C1
|
C:5RW302
|
3.6
|
54.5
|
1.0
|
CD
|
B:GLU236
|
3.8
|
58.5
|
1.0
|
C5
|
C:5RW302
|
4.1
|
53.8
|
1.0
|
CG
|
B:ARG235
|
4.2
|
25.7
|
1.0
|
OE1
|
B:GLU236
|
4.3
|
59.8
|
1.0
|
NH2
|
B:ARG235
|
4.5
|
33.1
|
1.0
|
NE2
|
H:GLN9
|
4.7
|
31.2
|
1.0
|
CD
|
B:ARG235
|
4.8
|
30.4
|
1.0
|
CD
|
H:GLN9
|
4.8
|
32.2
|
1.0
|
O
|
C:HOH445
|
4.8
|
32.8
|
1.0
|
CG
|
H:GLN9
|
4.9
|
26.5
|
1.0
|
CG
|
B:GLU236
|
4.9
|
42.6
|
1.0
|
O
|
H:HOH220
|
4.9
|
45.6
|
1.0
|
|
Fluorine binding site 4 out
of 5 in 7ala
Go back to
Fluorine Binding Sites List in 7ala
Fluorine binding site 4 out
of 5 in the Human Gch-Gfrp Inhibitory Complex
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Human Gch-Gfrp Inhibitory Complex within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:F302
b:49.4
occ:1.00
|
F19
|
D:5RW302
|
0.0
|
49.4
|
1.0
|
C6
|
D:5RW302
|
1.4
|
48.7
|
1.0
|
C3
|
D:5RW302
|
2.3
|
48.2
|
1.0
|
C4
|
D:5RW302
|
2.3
|
48.1
|
1.0
|
O
|
G:HOH225
|
3.1
|
22.0
|
1.0
|
O
|
G:HOH252
|
3.4
|
17.2
|
1.0
|
CD
|
G:PRO16
|
3.4
|
18.7
|
1.0
|
C1
|
D:5RW302
|
3.6
|
47.4
|
1.0
|
C2
|
D:5RW302
|
3.6
|
47.7
|
1.0
|
O
|
G:HOH223
|
3.7
|
27.0
|
1.0
|
CG
|
G:PRO16
|
3.8
|
20.3
|
1.0
|
O
|
G:HOH278
|
4.1
|
46.9
|
1.0
|
C5
|
D:5RW302
|
4.1
|
46.6
|
1.0
|
O
|
G:HOH213
|
4.2
|
35.1
|
1.0
|
CG
|
G:GLN9
|
4.4
|
25.8
|
1.0
|
CB
|
G:GLN9
|
4.5
|
22.4
|
1.0
|
N
|
G:PRO16
|
4.5
|
19.3
|
1.0
|
O
|
G:GLY15
|
4.5
|
19.8
|
1.0
|
C
|
G:GLY15
|
4.9
|
19.5
|
1.0
|
|
Fluorine binding site 5 out
of 5 in 7ala
Go back to
Fluorine Binding Sites List in 7ala
Fluorine binding site 5 out
of 5 in the Human Gch-Gfrp Inhibitory Complex
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Human Gch-Gfrp Inhibitory Complex within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
E:F302
b:50.1
occ:1.00
|
F19
|
E:5RW302
|
0.0
|
50.1
|
1.0
|
C6
|
E:5RW302
|
1.4
|
49.0
|
1.0
|
C4
|
E:5RW302
|
2.3
|
48.0
|
1.0
|
C3
|
E:5RW302
|
2.4
|
48.2
|
1.0
|
C2
|
E:5RW302
|
3.6
|
47.1
|
1.0
|
C1
|
E:5RW302
|
3.6
|
46.8
|
1.0
|
CD
|
F:PRO16
|
3.7
|
18.8
|
1.0
|
O
|
F:HOH235
|
4.0
|
28.3
|
1.0
|
O
|
F:GLY15
|
4.1
|
21.5
|
1.0
|
C5
|
E:5RW302
|
4.1
|
46.0
|
1.0
|
CG
|
F:PRO16
|
4.6
|
20.1
|
1.0
|
N
|
F:PRO16
|
4.8
|
20.3
|
1.0
|
O
|
E:HOH479
|
4.8
|
44.0
|
1.0
|
O
|
E:HOH454
|
4.8
|
37.9
|
1.0
|
O
|
F:HOH238
|
4.8
|
26.0
|
1.0
|
O
|
E:HOH402
|
4.9
|
49.1
|
1.0
|
C
|
F:GLY15
|
4.9
|
21.3
|
1.0
|
|
Reference:
R.Ebenhoch,
M.Bauer,
D.Reinert,
A.Kersting,
S.Huber,
A.Schmid,
I.Hinz,
M.Feiler,
K.Mueller,
H.Nar.
Using Hybrid Approaches to Study the Allosteric Regulation of Gtp Cyclohydrolase I To Be Published.
Page generated: Fri Aug 2 05:40:28 2024
|